Summit Corporation plc Share Price London S.E.
Stocks
GB00B02T3K57
Biotechnology & Medical Research
|
End-of-day quote
London S.E.
|
||
| - GBX | - |
|
| Market Cap | 10.21B 13.47B 11.98B 11.2B 19.16B 1,297B 19.45B 135B 52.01B 661B 50.54B 49.48B 2,129B | P/E 2026 * |
-14.5x | P/E 2027 * | -14.4x |
|---|---|---|---|---|---|
| Enterprise Value | 9.74B 12.85B 11.43B 10.68B 18.28B 1,237B 18.55B 129B 49.62B 631B 48.21B 47.2B 2,031B | EV / Sales 2026 * |
3,322x | EV / Sales 2027 * | 239x |
| Free-Float |
19.11% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Summit Corporation plc
| Manager | Title | Age | Since |
|---|---|---|---|
Mahkam Zanganeh
CEO | Chief Executive Officer | 55 | 24/07/2022 |
Robert Duggan
CEO | Chief Executive Officer | 81 | 31/03/2020 |
| Director of Finance/CFO | 48 | 01/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Duggan
CHM | Chairman | 81 | 31/01/2020 |
| Director/Board Member | 48 | 30/11/2019 | |
Mahkam Zanganeh
BRD | Director/Board Member | 55 | 10/11/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.16% | -0.36% | +49.37% | +94.17% | 74.46B | |
| -0.61% | +0.69% | +36.36% | +82.72% | 60.14B | |
| -2.54% | -0.21% | +6.34% | +31.72% | 48.15B | |
| -3.02% | -2.67% | +37.26% | +32.51% | 44.25B | |
| +0.31% | +7.94% | +340.88% | +643.82% | 43.99B | |
| -1.96% | -1.71% | +5.30% | +99.46% | 41.61B | |
| +3.32% | +3.49% | +11.18% | +51.23% | 29.97B | |
| +4.77% | +6.16% | +36.77% | +22.78% | 29.31B | |
| -4.86% | -8.24% | -24.60% | +330.06% | 24.93B | |
| Average | -0.05% | +1.97% | +55.43% | +154.28% | 44.09B | |
| Weighted average by Cap. | +0.17% | +1.83% | +60.06% | +145.78% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.93M 3.87M 3.44M 3.22M 5.5M 372M 5.58M 38.85M 14.94M 190M 14.51M 14.21M 611M | 41.86M 55.23M 49.1M 45.91M 78.55M 5.32B 79.72M 555M 213M 2.71B 207M 203M 8.73B |
| Net income | -698M -921M -819M -766M -1.31B -88.68B -1.33B -9.25B -3.56B -45.19B -3.45B -3.38B -146B | -740M -977M -868M -812M -1.39B -94.05B -1.41B -9.81B -3.77B -47.93B -3.66B -3.59B -154B |
| Net Debt | -470M -620M -551M -515M -882M -59.7B -895M -6.23B -2.39B -30.42B -2.33B -2.28B -98B | -200M -264M -235M -219M -376M -25.42B -381M -2.65B -1.02B -12.96B -990M -970M -41.73B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Select your edition
All financial news and data tailored to specific country editions
